Masataka Tsuge

22PUBLICATIONS
81CO-AUTHORS
Innate immunityChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 16, 2026
High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.

|May 04, 2026
A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota.

|Mar 31, 2026
Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol.

Yoshiko Doi, Hiroshi Aikata, Yumi Kosaka

|Feb 27, 2026
Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational Study.

Noriaki Iijima, Yasutaka Ishii, Shinya Nakamura

|Feb 07, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma.

Ryoichi Miura, Tomokazu Kawaoka, Saki Sueda

|Dec 22, 2025
Biopsy-Proven Reversal of F4 Cirrhosis in Classic Hepatic Glycogen Storage Disease Type IV: A 42-Year Follow-Up Without Transplantation.

Masaaki Mino, Nami Mori, Yumi Shimomura

Pageof 4

Frequent Collaborators

11 joint publications

Atsushi Ono

6 joint publications

Hatsue Fujino

6 joint publications

Shinsuke Uchikawa

5 joint publications

Shiro Oka